Výsledky vyhledávání - "Yuri, Yoshizawa"

Akademický článek

Cost-consequence of abatacept as first-line therapy in Japanese rheumatoid arthritis patients using IORRA real-world data.

Autor: Eiichi Tanaka, Eisuke Inoue, Ayako Shoji, Jonas Nilsson, Christos Papagiannopoulos, Devender Dhanda, Yuri Yoshizawa, Mai Abe, Kumiko Saka, Eri Sugano, Naohiro Sugitani, Moeko Ochiai, Rei Yamaguchi, Katsunori Ikari, Hisashi Yamanaka, Masayoshi Harigai

Publikováno v: PLoS ONE, Vol 17, Iss 11, p e0277566 (2022)

ObjectivesTo investigate the cost-effectiveness of abatacept (ABA) as first-line (1L) therapy in Japanese rheumatoid arthritis (RA) patients using data from the Institute of Rheumatology, Rheumatoid Arthritis database.MethodsA decision-analytic model

Externí odkaz: https://doaj.org/article/b9f67ed2f1674d6f857010e0f0230030

Zobrazit plný text záznamu

Plný text ve formátu HTML

Influence of concomitant methotrexate use on the clinical effectiveness, retention, and safety of abatacept in biologic-naïve patients with rheumatoid arthritis: Post-hoc subgroup analysis of the ORIGAMI study

Publikováno v: Modern Rheumatology. 33:271-278

Objectives We performed post-hoc analyses of the ORIGAMI study to investigate whether concomitant methotrexate (MTX) influences the clinical outcomes of abatacept in biologic-naïve patients with rheumatoid arthritis. Methods Enrolled patients (n = 3

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21ae05ea64c2e4e6121bf48304ba3d3d
https://doi.org/10.1093/mr/roac032

Zobrazit plný text záznamu

Long-term safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis: 3-year follow-up of a postmarketing surveillance

Autor: Masayoshi, Harigai, Katsuki, Tsuritani, Yuri, Yoshizawa, Tatsuya, Atsumi, Yoshiya, Tanaka

Publikováno v: Modern Rheumatology. 32:508-516

Objectives To analyse the long-term safety and effectiveness of abatacept for rheumatoid arthritis using real-world, Japanese, postmarketing surveillance data, focusing on serious infections and malignancies as priority events. Methods This 3-year, m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6992072b7367bba466507236175879a1
https://doi.org/10.1093/mr/roab050

Zobrazit plný text záznamu

Effectiveness and safety of subcutaneous abatacept in biologic-naïve RA patients at Week 52: A Japanese multicentre investigational study (ORIGAMI study)

Publikováno v: Modern rheumatology. 32(5)

Objectives To evaluate the effectiveness and safety of abatacept over 52 weeks in biologic-naïve rheumatoid arthritis (RA) patients with moderate disease activity in the prospective, 5-year, observational study (ORIGAMI study) in Japan. Methods Abat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdd79d2566687620a766f82cc3ef4275
https://pubmed.ncbi.nlm.nih.gov/34915575

Zobrazit plný text záznamu

The importance of specific citrullinated clusterin and vimentin found in a multi-coloured bead-based citrulline-peptide array system in rheumatoid arthritis

Autor: Yuri Yoshizawa, Toru Nakao, Katsuki Tsuritani, Takashi Yamada, Noriko Watanabe, Asako Chiba, William H. Robinson, Sachiko Miyake

Publikováno v: Clinical and experimental rheumatology. 40(5)

The importance of citrullination in rheumatoid arthritis (RA) has been reported, but the degree to which individual citrullinated proteins affect the onset and progression of RA is still unclear. We aimed to identify citrullinated proteins that may p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d36684cc72494c580c1eb16273f1466
https://pubmed.ncbi.nlm.nih.gov/34251306

Zobrazit plný text záznamu